Dr. Clare Craig

Right. It's not that hard to do because we were... I mean, you know, this is sort of a little little miracle that happened whereby huge swathes of the global population did not have the COVID problem until the vaccines rolled out. And you can use that as a control group because the timing of any problem should be different.

Right. It's not that hard to do because we were... I mean, you know, this is sort of a little little miracle that happened whereby huge swathes of the global population did not have the COVID problem until the vaccines rolled out. And you can use that as a control group because the timing of any problem should be different.

For Europe and the USA, which had COVID, well, not all of the USA, actually. You could probably divvy the USA up into regions that did and didn't have much in 2020. But broadly, there were regions that had it in 2020, and there were regions that didn't really have a problem until 2022. There's a two-year lag. So if you're not seeing a two-year lag...

For Europe and the USA, which had COVID, well, not all of the USA, actually. You could probably divvy the USA up into regions that did and didn't have much in 2020. But broadly, there were regions that had it in 2020, and there were regions that didn't really have a problem until 2022. There's a two-year lag. So if you're not seeing a two-year lag...

in the side effects of these, you know, in the problems that we're discussing, then it's not COVID. It's something else that everybody had in common, which is the vaccines. And more broadly, you know, when you've got a respiratory virus infection, the respiratory virus replicates in the mucosal epithelial cells lining the respiratory tract.

in the side effects of these, you know, in the problems that we're discussing, then it's not COVID. It's something else that everybody had in common, which is the vaccines. And more broadly, you know, when you've got a respiratory virus infection, the respiratory virus replicates in the mucosal epithelial cells lining the respiratory tract.

And those cells, you know, become little virus factories and they replicate and they die. And that makes a bit of a sore area, which causes you to have a cough. But broadly, it all happens on the lining of your lung. And you can sometimes detect RNA in the blood in people who get sick.

And those cells, you know, become little virus factories and they replicate and they die. And that makes a bit of a sore area, which causes you to have a cough. But broadly, it all happens on the lining of your lung. And you can sometimes detect RNA in the blood in people who get sick.

But even Fauci wrote a paper in January of this year where he's saying, well, you know, when we detect RNA in the blood, often it is just that. It's just debris from the virus. It's not whole virus particles in the blood. And so the number of people that actually have circulating virus is they would have been really super sick and the tiny, tiny number.

But even Fauci wrote a paper in January of this year where he's saying, well, you know, when we detect RNA in the blood, often it is just that. It's just debris from the virus. It's not whole virus particles in the blood. And so the number of people that actually have circulating virus is they would have been really super sick and the tiny, tiny number.

Now, the number of people who've been injected with a product that makes cells all over the body turn into spike protein factories, and then you get circulating spike, that number is enormous. And of course, spike is a pathological protein. And it was, you know, these vaccines had the entire spike sequence. They have 1,273 amino acid protein building blocks. They switched out two only.

Now, the number of people who've been injected with a product that makes cells all over the body turn into spike protein factories, and then you get circulating spike, that number is enormous. And of course, spike is a pathological protein. And it was, you know, these vaccines had the entire spike sequence. They have 1,273 amino acid protein building blocks. They switched out two only.

And the AstraZeneca didn't switch out any of them. So the entire most pathological part of the virus was being made by cells in the body and was circulating in the blood. So, yeah, that's what caused the problems. You know, I don't want to I understand you being a scientist about it completely. That's how we should approach this.

And the AstraZeneca didn't switch out any of them. So the entire most pathological part of the virus was being made by cells in the body and was circulating in the blood. So, yeah, that's what caused the problems. You know, I don't want to I understand you being a scientist about it completely. That's how we should approach this.

But actually, when you go back to first principles, it's bluntly obvious it was a vaccine, not the virus.

But actually, when you go back to first principles, it's bluntly obvious it was a vaccine, not the virus.

Right. So I think, I think I have a variety of theories, you know, I'm keeping a lot of theories going because I think we don't know this, you know, the evidence is still accumulating and that's fine. And so the big, the big question is how much of this is from inflammation of the heart?

Right. So I think, I think I have a variety of theories, you know, I'm keeping a lot of theories going because I think we don't know this, you know, the evidence is still accumulating and that's fine. And so the big, the big question is how much of this is from inflammation of the heart?

So the myocarditis story, you know, is bigger than what's been presented by the regulators and how much of it is just bond or coronary artery disease causing infarctions in people. And how much of it is potentially a bit of both actually. So if we take the myocarditis story first, we know that there were people who had myocarditis and got very sick at the time and had to be in hospital.

So the myocarditis story, you know, is bigger than what's been presented by the regulators and how much of it is just bond or coronary artery disease causing infarctions in people. And how much of it is potentially a bit of both actually. So if we take the myocarditis story first, we know that there were people who had myocarditis and got very sick at the time and had to be in hospital.